Exane Derivatives’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$81.1K Buy
1,017
+439
+76% +$35K 0.05% 282
2022
Q1
$60.8K Buy
+578
New +$60.8K 0.02% 547
2017
Q1
Sell
-1
Closed -$16 654
2016
Q4
$16 Hold
1
﹤0.01% 566
2016
Q3
$18 Hold
1
﹤0.01% 549
2016
Q2
$16 Sell
1
-9,999
-100% -$160K ﹤0.01% 531
2016
Q1
$166K Buy
+10,000
New +$166K 0.02% 183